CN117065157A - Monitoring method, system, equipment and storage medium for atomization treatment - Google Patents

Monitoring method, system, equipment and storage medium for atomization treatment Download PDF

Info

Publication number
CN117065157A
CN117065157A CN202311125909.5A CN202311125909A CN117065157A CN 117065157 A CN117065157 A CN 117065157A CN 202311125909 A CN202311125909 A CN 202311125909A CN 117065157 A CN117065157 A CN 117065157A
Authority
CN
China
Prior art keywords
liquid medicine
target
atomization
medicine
target liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202311125909.5A
Other languages
Chinese (zh)
Inventor
柴可
齐瑛
杜垚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huizhou Conmo Medical Technology Co ltd
Guangxi Bulu Medical Equipment Co ltd
Original Assignee
Huizhou Conmo Medical Technology Co ltd
Guangxi Bulu Medical Equipment Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huizhou Conmo Medical Technology Co ltd, Guangxi Bulu Medical Equipment Co ltd filed Critical Huizhou Conmo Medical Technology Co ltd
Priority to CN202311125909.5A priority Critical patent/CN117065157A/en
Publication of CN117065157A publication Critical patent/CN117065157A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0003Details of inhalators; Constructional features thereof with means for dispensing more than one drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0065Inhalators with dosage or measuring devices
    • A61M15/0066Inhalators with dosage or measuring devices with means for varying the dose size
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3327Measuring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3379Masses, volumes, levels of fluids in reservoirs, flow rates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/10Trunk
    • A61M2210/1025Respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/005Parameter used as control input for the apparatus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/40Respiratory characteristics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present application relates to the field of nebulization, and in particular, to a method, a system, an apparatus, and a storage medium for monitoring nebulization therapy. Wherein the method comprises the following steps: acquiring a use signal of a target user; processing the target liquid medicine according to the use signal, wherein the processing comprises atomizing the target liquid medicine or suspending atomizing the target liquid medicine; outputting the atomized target liquid medicine after the target liquid medicine is atomized; when the atomization of the target liquid medicine is suspended, determining the atomization amount of the target liquid medicine after the current atomization; and repeatedly executing the operation until the total atomization amount of the target liquid medicine reaches a preset range, and stopping atomizing the target liquid medicine. The application has the effect of accurately knowing how much dosage of liquid medicine is inhaled by the user and facilitating the subsequent treatment.

Description

Monitoring method, system, equipment and storage medium for atomization treatment
Technical Field
The present application relates to the field of nebulization, and in particular, to a method, a system, an apparatus, and a storage medium for monitoring nebulization therapy.
Background
The atomizer can be used for treating respiratory diseases, including asthma, chronic obstructive pneumonia, chronic bronchitis, common cold, etc. Compared with the traditional injection and drug taking method, the treatment method has small dosage and effectively reduces side effects, can treat diseases at home without going to a hospital, and is very convenient to use.
The prior atomizer has modes of high-frequency ultrasonic atomization, screen mesh type atomization, compression type atomization and the like. The fog-discharging modes of the medicine are active atomization medicine delivery, and the mode can not accurately know whether the patient inhales a small amount of medicine, so that the follow-up treatment is inconvenient.
The prior art is therefore still to be improved based on the above-mentioned problems.
Disclosure of Invention
The application aims to provide a patient atomization treatment monitoring method, a patient atomization treatment monitoring system, patient atomization treatment monitoring equipment and a storage medium, and aims to solve the problem that the patient cannot accurately know how much dosage of medicine is inhaled by the patient and follow-up treatment is inconvenient.
The application aims at providing a monitoring method for atomization treatment, which comprises the following steps:
acquiring a use signal of a target user;
processing the target liquid medicine according to the use signal, wherein the processing comprises atomizing the target liquid medicine or suspending atomizing the target liquid medicine;
outputting the atomized target liquid medicine after the target liquid medicine is atomized;
when the atomization of the target liquid medicine is suspended, determining the atomization amount of the target liquid medicine after the current atomization;
and repeatedly executing the operation until the total atomization amount of the target liquid medicine reaches a preset range, and stopping atomizing the target liquid medicine.
Through adopting above-mentioned technical scheme, through obtaining target user's use signal, accurate control atomizer atomizes or pauses the atomizing to the target liquid medicine, and the inside response subassembly of atomizer of being convenient for is responded to or calculate the produced atomizing volume of atomizing target liquid medicine, and medical personnel or patient's record of being convenient for observe the condition of taking medicine. Is beneficial to the subsequent treatment effect; by accurately controlling the inhalation amount of the target user, adverse reaction caused by too little inhalation or too much inhalation of the target user is avoided.
In one possible embodiment of the present application, the method further comprises:
the step of acquiring the usage signal of the target patient includes:
acquiring an induction air pressure value of an air pressure sensor corresponding to the atomizer;
based on the sensed air pressure value, analyzing an air pressure state in an air passage corresponding to the atomizer;
determining a respiration state of the target user according to the air pressure state;
and determining a use signal of the target user according to the breathing state.
Through adopting above-mentioned technical scheme, the atomizer discerns whether target user uses the atomizer to atomize target liquid medicine through target user's respiratory state, and target user accomplishes the switching of use signal through simple effectual respiratory state, makes target user can the accurate control atomizer atomize or pause atomizing to target liquid medicine, and the atomizing volume that accurate control atomizer produced avoids target user to inhale volume too much or too little.
In one possible embodiment of the present application, the method further comprises:
the step of determining the respiration state of the target user from the barometric pressure state comprises:
obtaining a standard air pressure value in an air passage corresponding to the atomizer;
when the sensed air pressure value is larger than the standard air pressure value, the air pressure state in the air passage of the atomizer is a positive pressure state, and the breathing state of the target user is determined to be an expiration state;
and when the sensed air pressure value is smaller than the standard air pressure value, the air pressure state in the air passage of the atomizer is a negative pressure state, and the breathing state of the target user is determined to be an inhalation state.
Through adopting above-mentioned technical scheme, the induced air pressure value that the air pressure sensor that sets up in through the atomizer sensed compares with the standard air pressure value in the atomizer air flue, easily discerns that target user is to the atomizer and breathes in or exhale the operation, makes target user can accurate control atomizer carry out atomizing target liquid medicine or pause atomizing target liquid medicine, or target user does not have operation control atomizer to the atomizer and pauses atomizing target liquid medicine, avoids when target user produces the maloperation, the atomizing volume of atomizer atomizing is too much, can not accurate reaction target user to the inhalation volume of target liquid medicine.
In one possible embodiment of the present application, the method further comprises:
the step of determining the atomization amount of the target medical liquid after the current atomization comprises the following steps:
when the total atomization amount of the target liquid medicine reaches a preset range, acquiring a first total atomization duration corresponding to the target liquid medicine;
acquiring the atomization efficiency of an atomization assembly of the atomizer for atomizing the target liquid medicine;
and calculating the inhalation atomization amount of the target user based on the first atomization total duration and the atomization efficiency.
By adopting the technical scheme, the inhalation atomization quantity of the target user is accurately calculated through the first atomization total duration and the atomization efficiency, so that the condition of taking medicine is conveniently recorded and observed, and the follow-up treatment effect is facilitated; by accurately controlling the inhalation amount of the target user, adverse reaction caused by too little inhalation or too much inhalation of the target user is avoided for treating the adverse diseases reasonably according to the dosage.
In one possible embodiment of the present application, the method further comprises:
the step of acquiring the usage signal of the target patient further includes:
acquiring a first flow data value of a first flow sensor corresponding to the atomizer;
determining a respiration state of the target user from the first flow data value;
And determining a use signal of the target user according to the breathing state.
Through adopting above-mentioned technical scheme, the atomizer discerns whether target user uses the atomizer to atomize target liquid medicine through target user's respiratory state, accomplishes the switching of use signal through simple respiratory state, makes target user can the accurate control atomizer atomize or pause atomizing target liquid medicine, and the atomizing volume that accurate control atomizer produced avoids target user to inhale volume too much or too little.
In one possible embodiment of the present application, the method further comprises:
the step of determining the atomization amount of the target medical liquid after the current atomization comprises the following steps:
when the total atomization amount of the target liquid medicine reaches a preset range, obtaining a second total atomization duration corresponding to the target liquid medicine;
determining a second flow data value for a second flow sensor within the second total nebulization duration;
the second flow data value is determined as the inhalation aerosol quantity of the target user.
By adopting the technical scheme, the flow sensor accurately senses the inhalation atomization amount of the target user on the target liquid medicine, so that the recording and the observation are convenient, and the follow-up treatment is facilitated; by accurately controlling the inhalation amount of the target user, adverse reaction caused by too little inhalation or too much inhalation of the target user is avoided for treating the adverse diseases reasonably according to the dosage.
In one possible embodiment of the present application, the method further comprises:
the step of determining the usage signal of the target user from the respiration state comprises:
generating an inhalation signal when the respiratory state is an inhalation state;
generating an expiration signal when the respiratory state is an expiration state;
wherein the inhalation signal and the exhalation signal are both the use signal;
the processing the target liquid medicine according to the use signal comprises the following steps:
atomizing the target liquid medicine when the using signal is an inhalation signal;
and when the use signal is an expiration signal, suspending atomization of the target liquid medicine.
By adopting the technical scheme, the electric signal is correspondingly generated according to the inhalation state or the exhalation state of the target user, so that the atomizer can be accurately controlled to atomize or pause atomizing the target liquid medicine, feedback can be effectively built in time, and adverse reaction caused by too little inhalation of the target user or too much inhalation can be avoided.
In one possible embodiment of the present application, the method further comprises:
the method further comprises the steps of:
establishing an atomized medicine library corresponding to the target user;
Deleting a first mark corresponding to the target liquid medicine from the atomized medicine library after the target liquid medicine is atomized;
if the target user is detected to atomize in the current period, matching a second identifier corresponding to the first liquid medicine atomized at present with the medicine identifier in the atomized medicine library;
if the atomized medicine library has medicine identifications matched with the second identifications, atomizing the first medicine liquid;
and if the atomized medicine library does not have the medicine identification matched with the second identification, sending out prompt information.
Through adopting above-mentioned technical scheme, when following the doctor's advice, target user uses an atomizer to atomize multiple target liquid medicine, when making target user inhale compound liquid medicine in order to reach good treatment, the required atomizing liquid medicine sign that carries out of atomizer is input through atomizing medicine storehouse, can discern the target liquid medicine that has atomized through the atomizer when target user uses the atomizer, when the target liquid medicine that has been atomized is atomized again, remind target user through sending prompt message, avoid target user to take medicine repeatedly, increase the possibility that leads to the adverse reaction because the excessive easy of inhalation dosage.
In one possible embodiment of the present application, the method further comprises:
the method further comprises the steps of:
after the atomization of the target liquid medicine is completed, the identity of the target user is associated with the first identity;
if the target user is detected to atomize in the current period, judging whether a third identifier corresponding to the second liquid medicine which is atomized currently is matched with a liquid medicine identifier associated with the target user or not;
if the third identifier is matched with the liquid medicine identifier associated with the target user, a prompt message is sent;
and if the third identifier is not matched with the liquid medicine identifier associated with the target user, atomizing the second liquid medicine.
By adopting the technical scheme, in the atomized medicine library, after the atomization of the target medicine liquid is completed, the identity of the target user is associated with the first identity corresponding to the target medicine liquid; the step that the medicine liquid identification in the atomized medicine warehouse needs to be added again after being deleted is reduced, and the target user can regularly atomize the same target medicine liquid according to the doctor's advice through the atomizer, so that the possibility that adverse reaction is easily caused by excessive inhaled medicine quantity due to repeated medicine use of the target user is avoided.
The second object of the present application is to provide a monitoring system for nebulization therapy, the system comprising:
using a signal acquisition module: for acquiring a usage signal of the target patient;
the target liquid medicine treatment module: the device is used for processing the target liquid medicine according to the use signal, and the processing comprises atomizing the target liquid medicine or suspending atomizing the target liquid medicine;
the target liquid medicine output module: the device is used for outputting the atomized target liquid medicine after the target liquid medicine is atomized;
the atomization amount determining module is used for: when the atomization of the target liquid medicine is suspended, determining the atomization amount of the target liquid medicine after the current atomization;
and an atomization stopping module: and repeating the above operation until the total atomization amount of the target liquid medicine reaches a preset range, and stopping atomizing the target liquid medicine.
By adopting the technical scheme, the atomizer is precisely controlled to atomize or pause to atomize the target liquid medicine by acquiring the use signal of the target user, so that the induction component inside the atomizer is convenient to sense or calculate the atomization amount of the atomized target liquid medicine by the atomizer, and the follow-up treatment is convenient to record and observe; by accurately controlling the inhalation amount of the target user, adverse reaction caused by too little inhalation or too much inhalation of the target user is avoided.
The third object of the present application is to provide a monitoring device for nebulization therapy, comprising:
the device comprises a memory and a processor, wherein the memory stores a computer program which can be loaded by the processor and execute the monitoring method of the atomization treatment.
A fourth object of the present application is to provide a storage medium.
The fourth object of the present application is achieved by the following technical solutions:
a storage medium in which a computer program is stored that can be loaded by a processor and that performs a method of monitoring an aerosolized treatment as described above.
In summary, the present application includes at least one of the following beneficial technical effects:
1. by acquiring the use signal of the target user, the atomizer is precisely controlled to atomize or pause to atomize the target liquid medicine, so that the sensing assembly in the atomizer can sense or calculate the atomization amount of the atomized target liquid medicine by the atomizer, and the follow-up treatment can be facilitated by recording and observing; by accurately controlling the inhalation amount of the target user, adverse reaction caused by too little inhalation or too much inhalation of the target user is avoided.
2. When the medical advice is followed, the target user uses one atomizer to atomize a plurality of medicine liquids, and the target user inhales the compound medicine liquid to achieve a good treatment effect, the atomized target medicine liquid ID required by the atomizer is input through the atomized medicine library, the atomized target medicine liquid is distinguished, and when the atomized target medicine liquid is atomized again, the target user is reminded by sending prompt information, so that the possibility that adverse reaction is easily caused by excessive inhaled medicine amount is avoided from being increased due to repeated medicine use of the target user.
Drawings
FIG. 1 is a schematic flow chart of a method for monitoring an atomization treatment according to an embodiment of the present application;
fig. 2 is a schematic diagram of a virtual structure of a monitoring system for nebulization therapy according to an embodiment of the present application.
Detailed Description
For the purpose of making the objects, technical solutions and advantages of the embodiments of the present application more apparent, the technical solutions of the embodiments of the present application will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present application, and it is apparent that the described embodiments are some embodiments of the present application, but not all embodiments of the present application. All other embodiments, which can be made by those skilled in the art based on the embodiments of the application without making any inventive effort, are intended to be within the scope of the application.
In addition, the term "and/or" herein is merely an association relationship describing an association object, and means that three relationships may exist, for example, a and/or B may mean: a exists alone, A and B exist together, and B exists alone. In this context, unless otherwise specified, the term "/" generally indicates that the associated object is an "or" relationship.
Embodiments of the application are described in further detail below with reference to the drawings.
An embodiment of the present application provides a method for monitoring an atomization treatment, and referring to fig. 1, a main flow of the method is described as follows:
s1: acquiring a use signal of a target user;
the target user is a user currently using the atomizer, and the atomizer atomizes or pauses to atomize the target liquid medicine through the use signal.
S2: processing the target liquid medicine according to the use signal, wherein the processing comprises atomizing the target liquid medicine or suspending atomizing the target liquid medicine;
the electronic atomizer processes the target liquid medicine according to the use signal of the target user, wherein the processing comprises atomizing the target liquid medicine by the electronic atomizer or suspending atomizing the target liquid medicine by the electronic atomizer.
S3: outputting the atomized target liquid medicine after the target liquid medicine is atomized;
the electronic atomizer is used for atomizing the target liquid medicine, meanwhile, the atomized target liquid medicine is conveyed to the mouth and nose of a target user through the air passage of the electronic atomizer, and the target user can inhale the target liquid medicine into the respiratory tract through breathing, so that the symptoms can be effectively treated.
S4: when the atomization of the target liquid medicine is suspended, determining the atomization amount of the target liquid medicine after the current atomization;
When the electronic atomizer pauses to atomize the target liquid medicine, the current atomization amount of the atomized target liquid medicine is determined through sensing or calculation of the sensing component in the electronic atomizer, so that the current inhalation amount of a target user can be conveniently recorded or observed.
S5: and repeating the steps S1 to S4 until the total atomization amount of the target liquid medicine reaches a preset range, and stopping atomizing the target liquid medicine.
When the atomization amount of the electronic atomizer to the target liquid medicine reaches the preset range, the electronic atomizer stops atomizing the target liquid medicine, and the possibility of excessive or repeated medicine use of the target user is avoided.
Specifically, in some possible embodiments, the step of obtaining the usage signal of the target patient comprises:
acquiring an induction air pressure value of an air pressure sensor corresponding to the atomizer;
based on the sensed air pressure value, analyzing an air pressure state in an air passage corresponding to the atomizer;
determining a respiration state of the target user according to the air pressure state;
And determining a use signal of the target user according to the breathing state.
Wherein, in general, the target user has different breathing states with or without the use of the electronic nebulizer; an air pressure sensor is arranged in the air passage of the electronic atomizer, and can sense the air pressure in the air passage of the atomizer and generate a sensed air pressure value; the breathing state of the target user can influence the air pressure sensor in the air passage of the electronic atomizer, so that the sensed air pressure value sensed by the air pressure sensor changes, the air pressure state in the air passage of the atomizer is analyzed through the change of the sensed air pressure value, and the breathing state of the target user is finally determined according to the air pressure state in the air passage of the atomizer; and determining a use signal of the target user through the breathing state of the target user, and accurately controlling the atomizer to atomize or pause atomizing the target liquid medicine through the use signal by the target user.
Specifically, in some possible embodiments, the step of determining the respiration state of the target user from the barometric pressure state comprises:
obtaining a standard air pressure value in an air passage corresponding to the atomizer;
when the sensed air pressure value is larger than the standard air pressure value, the air pressure state in the air passage of the atomizer is a positive pressure state, and the breathing state of the target user is determined to be an expiration state;
And when the sensed air pressure value is smaller than the standard air pressure value, the air pressure state in the air passage of the atomizer is a negative pressure state, and the breathing state of the target user is determined to be an inhalation state.
The air passage of the electronic atomizer is internally provided with an air pressure sensor, and when no one performs suction action on the electronic atomizer, the standard air pressure value in the air passage of the electronic atomizer is standard atmospheric pressure which is approximately equal to 0.1013Mpa; when a target user operates the electronic atomizer, the air pressure in the air passage of the electronic atomizer sensed by the air pressure sensor changes along with the breathing action of the target user, the electronic atomizer acquires the air pressure of the air passage in the electronic atomizer in real time through the air pressure sensor, and the sensed air pressure value is uploaded to the terminal in real time by the air pressure sensor for comparison. When a target user inhales the electronic atomizer, the air pressure in the air passage of the electronic atomizer is reduced to form a negative pressure state, the sensed air pressure value is smaller than the standard air pressure value, and the current breathing state of the target user is confirmed to be an inhalation state, so that the electronic atomizer starts to atomize atomized liquid; when the target user exhales to the electronic atomizer, the air pressure in the air passage of the electronic atomizer is increased to form a positive pressure state, the sensing air pressure value is larger than the standard air pressure value, and the current breathing state of the target user is confirmed to be an exhaling state, so that the electronic atomizer pauses to atomize the target liquid medicine.
Specifically, in some possible embodiments, the step of determining the amount of nebulization of the target medical fluid after the current nebulization comprises:
when the total atomization amount of the target liquid medicine reaches a preset range, acquiring a first total atomization duration corresponding to the target liquid medicine;
acquiring the atomization efficiency of an atomization assembly of the atomizer for atomizing the target liquid medicine;
and calculating the inhalation atomization amount of the target user based on the first atomization total duration and the atomization efficiency.
According to the medical advice or the reasonable usage dosage of the target liquid medicine, the preset range is used when the background of the electronic atomizer is preset reasonably, so that the possibility that the target liquid medicine is used by a target user in excess or reused is avoided. For example, the target medicine is budesonide which is commonly used for bronchial asthma, bronchiolitis, bronchopneumonia and the like, the proper amount of the target medicine is 1ml-2ml each time, the preferential preset range is 1.7ml-2ml milligrams, and when the electronic atomizer atomizes the target medicine liquid for multiple times, the atomizer stops atomizing the target medicine liquid when the total atomization amount of the target medicine liquid is 1.7ml-2 ml; the method comprises the steps of setting the time length of using an electronic atomizer by a target user to be 5 minutes, maintaining an inhalation state for 3 minutes and an exhalation state for 2 minutes, namely obtaining the first total atomization time length of target liquid medicine to be 3 minutes, obtaining the atomization efficiency of an atomization component of the atomizer for atomizing the target liquid medicine to be 0.25ml/min, enabling the atomization efficiency of different atomizers to be different, calculating the total atomization amount of the target liquid medicine based on the first total atomization time length to be 3 minutes, namely, the inhalation atomization amount of the target user to be 3min 0.25 ml/min=0.75 ml, accurately displaying and recording the inhalation atomization amount of the target user, avoiding excessive absorption of the user, and facilitating subsequent treatment. When the first atomization total duration corresponding to the target liquid medicine is 7min, the inhalation atomization amount of the target user is 7min x 0.25 ml/min=1.75 ml;1.75ml is in the preset range, and the electronic atomizer sends prompt information to prompt the electronic atomizer to stop atomizing the target liquid medicine, and when the total first atomization duration is 8min or more, the electronic atomizer does not calculate the inhalation atomization amount of a target user, and the electronic atomizer automatically sets a warning line to stop atomizing the target liquid medicine.
Specifically, in some possible embodiments, the step of obtaining the usage signal of the target patient further comprises:
acquiring a first flow data value of a first flow sensor corresponding to the atomizer;
determining a respiration state of the target user from the first flow data value;
and determining a use signal of the target user according to the breathing state.
The electronic atomizer comprises an air passage, a first flow sensor, a second flow sensor, a third flow sensor and a fourth flow sensor, wherein the first flow sensor is arranged in the air passage of the electronic atomizer, and when no person performs suction action on the electronic atomizer, a first flow data value of the first flow sensor is 0; when a target user operates the electronic atomizer, along with the breathing action of the target user, the inhalation flow of a human body is quite small relative to the exhalation flow under normal conditions, the airflow flow of an air channel in the electronic atomizer is obtained in real time through a first flow sensor, the first flow sensor uploads the sensed first flow data value to a terminal in real time for comparison, the magnitude of the airflow sensed by the user during breathing under normal conditions can be pre-recorded, the inhalation is in a larger numerical range, and the exhalation is in a smaller numerical range. When the target user inhales the electronic atomizer, the first flow data value is larger than the first flow data value when the target user exhales the electronic atomizer, the first flow data value is in a larger numerical range, and the current breathing state of the target user is confirmed to be an inhaling state, so that the electronic atomizer starts to atomize atomized liquid; when the target user exhales to the electronic atomizer, the first flow data value is in a smaller numerical range, and the current breathing state of the target user is confirmed to be the exhalation state, so that the electronic atomizer pauses to atomize the target liquid medicine.
Specifically, in some possible embodiments, the step of determining the amount of nebulization of the target medical fluid after the current nebulization comprises:
when the total atomization amount of the target liquid medicine reaches a preset range, obtaining a second total atomization duration corresponding to the target liquid medicine;
determining a second flow data value for a second flow sensor within the second total nebulization duration;
the second flow data value is determined as the inhalation aerosol quantity of the target user.
According to the medical advice or the reasonable usage dosage of the target liquid medicine, the preset range is used when the background of the electronic atomizer is preset reasonably, so that the possibility that the target liquid medicine is used by a target user in excess or reused is avoided. For example, the target medicine is budesonide which is commonly used for bronchial asthma, bronchiolitis, bronchopneumonia and the like, the proper amount of the target medicine is 1ml-2ml each time, the preferential preset range is 1.7ml-2ml milligrams, and when the electronic atomizer atomizes the target medicine liquid for multiple times, the atomizer stops atomizing the target medicine liquid when the total atomization amount of the target medicine liquid is 1.7ml-2 ml; the time length of using the electronic atomizer by the target user is set to be 9 minutes, the inhalation state is maintained for 5 minutes, the exhalation state is maintained for 4 minutes, namely, the second total atomization time length of the obtained target liquid medicine is set to be 5 minutes, the second flow data value of the second flow sensor in the second total atomization time length is displayed to be 2ml of atomized target liquid medicine flowing through the airway, namely, the inhalation atomization amount of the target user is set to be 2ml, the inhalation atomization amount of the target user is accurately displayed and recorded, the excessive absorption of the user is avoided, and the follow-up treatment is facilitated. When the second atomization total duration corresponding to the target liquid medicine is 4min, the inhalation atomization amount of the target user is 1.6ml;1.6ml is in the preset range, and the electronic atomizer sends prompt information to prompt the electronic atomizer to stop atomizing the target liquid medicine, and when the total second atomization duration is 5min or more, the electronic atomizer does not calculate the inhalation atomization amount of the target user, and the electronic atomizer automatically sets a warning line to stop atomizing the target liquid medicine.
Specifically, in some possible embodiments, the step of determining the usage signal of the target user by the respiration state includes:
generating an inhalation signal when the respiratory state is an inhalation state;
generating an expiration signal when the respiratory state is an expiration state;
wherein the inhalation signal and the exhalation signal are both the use signal;
the processing the target liquid medicine according to the use signal comprises the following steps:
atomizing the target liquid medicine when the using signal is an inhalation signal;
and when the use signal is an expiration signal, suspending atomization of the target liquid medicine.
When the target user uses the electronic atomizer, the electronic atomizer judges the breathing state of the target user through the air pressure sensor or the flow sensor. When the breathing state of the target user is the inspiration state, the electronic atomizer generates a corresponding electric signal through sensing of the air pressure sensor or the flow sensor, namely an inspiration signal, and the preferable inspiration signal is 1; when the breathing state of the target user is the breathing state, the electronic atomizer generates corresponding electric signals through sensing of the air pressure sensor or the flow sensor, namely breathing signals, and preferably the breathing signals are 0; the inspiration signal and the expiration signal are both using signals, and the generation and transmission of the inspiration signal or the expiration signal are realized through binary system. After the inhalation signal or the exhalation signal is generated, the electronic atomizer carries out different treatments on the target liquid medicine according to different using signals, and when the using signals are the inhalation signals, the electronic atomizer atomizes the target liquid medicine; when the usage signal is an exhalation signal, atomization of the target medical fluid is suspended.
Specifically, in some possible embodiments, the method further comprises:
establishing an atomized medicine library corresponding to the target user;
deleting a first mark corresponding to the target liquid medicine from the atomized medicine library after the target liquid medicine is atomized;
if the target user is detected to atomize in the current period, matching a second identifier corresponding to the first liquid medicine atomized at present with the medicine identifier in the atomized medicine library;
if the atomized medicine library has medicine identifications matched with the second identifications, atomizing the first medicine liquid;
and if the atomized medicine library does not have the medicine identification matched with the second identification, sending out prompt information.
The method comprises the steps of establishing an atomized medicine library corresponding to a target user, inputting a first identifier, a dosage, a using interval and the like of a target medicine liquid which is required to be atomized into the atomized medicine library of the electronic atomizer according to a doctor's advice, and storing medicines and using methods required by atomization treatment of the target user through the database. When the electronic atomizer needs to start an atomization function, comparing a second identifier of target liquid medicine placed on the electronic atomizer with a first identifier in an atomized medicine library, and if the first identifier existing in the atomized medicine library is matched with the second identifier corresponding to the target liquid medicine, namely the current atomized medicine of a target user accords with a doctor's advice, starting atomizing the target liquid medicine by the electronic atomizer. If the first identifier in the atomized medicine library is not matched with the second identifier corresponding to the target medicine liquid, determining that the atomized target medicine liquid currently used by the target user does not accord with the medical advice, and sending prompt information to remind the target user so as to avoid the influence of the treatment caused by the medicine misplacement of the target user.
Deleting a first mark corresponding to the target liquid medicine from the atomized medicine library after the target liquid medicine conforming to the medical advice is atomized; in the current period, when the electronic atomizer needs to continuously start the atomization function, the second identifier of the first liquid medicine placed on the electronic atomizer is matched with the first identifier in the atomized medicine library, if the first identifier existing in the atomized medicine library is matched with the second identifier corresponding to the first liquid medicine, namely, the medicine which is currently required to be atomized and treated by the target user accords with the medical advice, the target user is unused, the risk of repeated medicine use does not exist, and the electronic atomizer starts to atomize the first liquid medicine. If the medicine in the atomized medicine library is not matched with the second mark corresponding to the first medicine liquid, the first medicine liquid is determined to be not in line with the medical advice or the medicine liquid is used by the target user in the current period, and the electronic atomizer sends out prompt information to remind the target user, so that the influence on the treatment effect caused by medicine mistaking or repeated medicine taking in a short period is avoided. And the like, until the medicine identification corresponding to the medicine required by the atomization treatment of the target user is completely deleted in the atomization medicine library, the target user finishes the atomization treatment of the current period.
Specifically, in some possible embodiments, the method further comprises:
after the atomization of the target liquid medicine is completed, the identity of the target user is associated with the first identity;
if the target user is detected to atomize in the current period, judging whether a third identifier corresponding to the second liquid medicine which is atomized currently is matched with a liquid medicine identifier associated with the target user or not;
if the third identifier is matched with the liquid medicine identifier associated with the target user, a prompt message is sent;
and if the third identifier is not matched with the liquid medicine identifier associated with the target user, atomizing the second liquid medicine.
According to the medical advice, a first mark, a dosage, a using interval and the like of a target liquid medicine which is required to be atomized by a target user are input into an atomized medicine library of the electronic atomizer, and medicines and using methods required by atomization treatment of the target user are stored through the database. The target user logs in the corresponding electronic atomizer through the unique identity mark, the target user puts the first liquid medicine into the electronic atomizer for atomization, and after the atomization of the first liquid medicine is completed, the identity mark of the target user is associated with the first identity mark of the first liquid medicine without deleting from the atomized medicine library. Preferably, the current period is 12 hours, the day has two periods, in the current period, when the electronic atomizer needs to atomize the second liquid medicine, the third identifier of the second liquid medicine needs to be matched with the liquid medicine identifier associated with the target user in the atomized medicine library, when the third identifier of the second liquid medicine used by the current target user is matched with the liquid medicine identifier associated with the target user, the second liquid medicine and the target liquid medicine are determined to be re-used medicines in the current period, and the electronic atomizer sends prompt information to prompt the target user to use errors.
When the third identification of the second liquid medicine is not matched with the liquid medicine identification associated with the target user, namely, the second liquid medicine and the target liquid medicine are judged to be not repeatedly used in the current period, the electronic atomizer starts to atomize the second liquid medicine.
After entering the next period, unbinding the identity identification of the target user and the first identification corresponding to the target liquid medicine; the current target user identity identification can be associated with the first identification of the target liquid medicine again, namely the second liquid medicine is judged to be nebulizable in the current period, the electronic nebulizer starts to nebulize the target liquid medicine, and so on.
Another embodiment of the present application provides a monitoring system for nebulized therapy, referring to fig. 2, the monitoring system for nebulized therapy includes:
using the signal acquisition module 100: for acquiring a usage signal of the target patient;
the target medical fluid treatment module 200: the device is used for processing the target liquid medicine according to the use signal, and the processing comprises atomizing the target liquid medicine or suspending atomizing the target liquid medicine;
the target medical fluid output module 300: the device is used for outputting the atomized target liquid medicine after the target liquid medicine is atomized;
the atomization amount determination module 400: when the atomization of the target liquid medicine is suspended, determining the atomization amount of the target liquid medicine after the current atomization;
Atomization stopping module 500: and repeating the above operation until the total atomization amount of the target liquid medicine reaches a preset range, and stopping atomizing the target liquid medicine.
The function of each module and the logic connection between each module of the monitoring system for the atomization treatment provided in this embodiment can implement each step of the foregoing embodiment, so that the same technical effects as those of the foregoing embodiment can be achieved, and the principle analysis can refer to the related description of the steps of the foregoing monitoring method for the atomization treatment, which is not described herein.
In some possible embodiments, the usage signal acquisition module 100 includes:
an induced air pressure value acquisition unit: acquiring an induction air pressure value of an air pressure sensor corresponding to the atomizer;
air pressure state analysis unit: based on the sensed air pressure value, analyzing an air pressure state in an air passage corresponding to the atomizer;
a respiratory state determination unit: determining a respiration state of the target user according to the air pressure state;
a use signal determination unit: and determining a use signal of the target user according to the breathing state.
The function of each module and the logic connection between each module of the monitoring system for the atomization treatment provided in this embodiment can implement each step of the foregoing embodiment, so that the same technical effects as those of the foregoing embodiment can be achieved, and the principle analysis can refer to the related description of the steps of the foregoing monitoring method for the atomization treatment, which is not described herein.
In some possible embodiments, the atomization amount determination module 400 includes:
a first atomization total duration acquisition unit: when the total atomization amount of the target liquid medicine reaches a preset range, acquiring a first total atomization duration corresponding to the target liquid medicine;
atomization efficiency acquisition unit: acquiring the atomization efficiency of an atomization assembly of the atomizer for atomizing the target liquid medicine;
inhalation atomization amount calculating unit: and calculating the inhalation atomization amount of the target user based on the first atomization total duration and the atomization efficiency.
The function of each module and the logic connection between each module of the monitoring system for the atomization treatment provided in this embodiment can implement each step of the foregoing embodiment, so that the same technical effects as those of the foregoing embodiment can be achieved, and the principle analysis can refer to the related description of the steps of the foregoing monitoring method for the atomization treatment, which is not described herein.
In some possible embodiments, the usage signal acquisition module 100 further comprises:
a first flow data value acquisition unit: acquiring a first flow data value of a first flow sensor corresponding to the atomizer;
a respiratory state determination unit: determining a respiration state of the target user from the first flow data value;
A use signal determination unit: and determining a use signal of the target user according to the breathing state.
The function of each module and the logic connection between each module of the monitoring system for the atomization treatment provided in this embodiment can implement each step of the foregoing embodiment, so that the same technical effects as those of the foregoing embodiment can be achieved, and the principle analysis can refer to the related description of the steps of the foregoing monitoring method for the atomization treatment, which is not described herein.
In some possible embodiments, the atomization amount determination module 400 further includes:
a second atomization total duration acquisition unit: when the total atomization amount of the target liquid medicine reaches a preset range, obtaining a second total atomization duration corresponding to the target liquid medicine;
a second flow data value determination unit: determining a second flow data value for a second flow sensor within the second total nebulization duration;
inhalation atomization amount determining unit: the second flow data value is determined as the inhalation aerosol quantity of the target user.
The function of each module and the logic connection between each module of the monitoring system for the atomization treatment provided in this embodiment can implement each step of the foregoing embodiment, so that the same technical effects as those of the foregoing embodiment can be achieved, and the principle analysis can refer to the related description of the steps of the foregoing monitoring method for the atomization treatment, which is not described herein.
In some possible embodiments, further comprising:
the atomization medicine library establishment module: establishing an atomized medicine library corresponding to the target user;
and a deletion module: deleting the ID corresponding to the first target liquid medicine from the atomized medicine library after the first target liquid medicine is atomized;
and a comparison module: when the atomizer atomizes the second target liquid medicine, comparing the ID corresponding to the second target liquid medicine with the ID in the atomized medicine library;
and an atomization module: if the ID in the atomized medicine library is matched with the ID corresponding to the second target medicine liquid, determining that the second target medicine liquid is not atomized, and atomizing the second target medicine liquid;
the prompt information sending module: and if the ID in the atomized medicine library is not matched with the ID corresponding to the second target medicine liquid, determining that the second target medicine liquid is atomized, and sending out prompt information.
The function of each module and the logic connection between each module of the monitoring system for the atomization treatment provided in this embodiment can implement each step of the foregoing embodiment, so that the same technical effects as those of the foregoing embodiment can be achieved, and the principle analysis can refer to the related description of the steps of the foregoing monitoring method for the atomization treatment, which is not described herein.
In some possible embodiments, further comprising:
and (3) an association module: after atomization of the first target liquid medicine is completed, associating the ID of the target user with the ID corresponding to the first target liquid medicine;
and a judging module: in the current period, when the atomizer corresponding to the ID of the target user atomizes the second target medicine liquid, judging whether the second target medicine liquid is consistent with the first target medicine liquid or not;
the prompt information module: if the second target liquid medicine is consistent with the first target liquid medicine, sending out prompt information;
and (3) carrying out an atomization module: and atomizing the second target liquid medicine if the second target liquid medicine is inconsistent with the first target liquid medicine.
The function of each module and the logic connection between each module of the monitoring system for the atomization treatment provided in this embodiment can implement each step of the foregoing embodiment, so that the same technical effects as those of the foregoing embodiment can be achieved, and the principle analysis can refer to the related description of the steps of the foregoing monitoring method for the atomization treatment, which is not described herein.
The embodiment of the application also provides monitoring equipment for the atomization treatment, which comprises a memory and a processor, wherein the memory is stored with a computer program which can be loaded by the processor and execute the monitoring method for the atomization treatment.
The embodiment of the application also provides a storage medium, wherein a computer program capable of being loaded by a processor and executing the monitoring method of the atomization treatment is stored.
The storage medium provided in this embodiment, after being loaded and executed on a processor, implements the steps of the foregoing embodiment, so that the same technical effects as those of the foregoing embodiment can be achieved, and the principle analysis can be seen from the related description of the foregoing method steps, which is not further described herein.
The storage medium includes, for example: a U-disk, a removable hard disk, a Read-Only Memory (ROM), a random access Memory (Random Access Memory, RAM), a magnetic disk, or an optical disk, or other various media capable of storing program codes.
The steps of a method or algorithm described in connection with the embodiments disclosed herein may be embodied directly in hardware, in a software module executed by a processor, or in a combination of the two. The software modules may be disposed in Random Access Memory (RAM), memory, read Only Memory (ROM), electrically programmable ROM, electrically erasable programmable ROM, registers, hard disk, a removable disk, a CD-ROM, or any other form of storage medium known in the art.
In the description of the present specification, a description referring to terms "one embodiment," "some embodiments," "examples," "specific examples," or "some examples," etc., means that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the present invention. In this specification, schematic representations of the above terms are not necessarily directed to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples. Furthermore, the different embodiments or examples described in this specification and the features of the different embodiments or examples may be combined and combined by those skilled in the art without contradiction.
Furthermore, the terms "first," "second," and the like, may expressly or implicitly include at least one such feature. In the description of the present invention, the meaning of "a plurality" is at least two, such as two, three, etc., unless explicitly defined otherwise, for descriptive purposes only and not to be construed as indicating or implying relative importance or implicitly indicating the number of technical features indicated.
Thus, any process or method descriptions in flow charts or otherwise described herein may be understood as representing modules, segments, or portions of code which include one or more executable instructions for implementing specific logical functions or steps of the process, and further implementations are included within the scope of the preferred embodiment of the present application in which functions may be executed out of order from that shown or discussed, including substantially concurrently or in reverse order, depending on the functionality involved, as would be understood by those reasonably skilled in the art of the embodiments of the present application.
The embodiments of the present application are all preferred embodiments of the present application, and are not intended to limit the scope of the present application in this way, therefore: all equivalent changes in structure, shape and principle of the application should be covered in the scope of protection of the application.

Claims (10)

1. A method of monitoring an aerosolized therapy, comprising:
acquiring a use signal of a target user;
processing the target liquid medicine according to the use signal, wherein the processing comprises atomizing the target liquid medicine or suspending atomizing the target liquid medicine;
outputting the atomized target liquid medicine after the target liquid medicine is atomized;
When the atomization of the target liquid medicine is suspended, determining the atomization amount of the target liquid medicine after the current atomization;
and repeatedly executing the operation until the total atomization amount of the target liquid medicine reaches a preset range, and stopping atomizing the target liquid medicine.
2. A method of monitoring nebulized therapy according to claim 1, wherein the step of obtaining a usage signal of the target patient comprises:
acquiring an induction air pressure value of an air pressure sensor corresponding to the atomizer;
based on the sensed air pressure value, analyzing an air pressure state in an air passage corresponding to the atomizer;
determining a respiration state of the target user according to the air pressure state;
and determining a use signal of the target user according to the breathing state.
3. A method of monitoring nebulization therapy according to claim 2, wherein the step of determining the respiration state of the target user from the barometric pressure state comprises:
obtaining a standard air pressure value in an air passage corresponding to the atomizer;
when the sensed air pressure value is larger than the standard air pressure value, the air pressure state in the air passage of the atomizer is a positive pressure state, and the breathing state of the target user is determined to be an expiration state;
And when the sensed air pressure value is smaller than the standard air pressure value, the air pressure state in the air passage of the atomizer is a negative pressure state, and the breathing state of the target user is determined to be an inhalation state.
4. A method of monitoring an aerosolized treatment according to claim 2 wherein the step of determining the amount of aerosolization of the target medical fluid following current aerosolization comprises:
when the total atomization amount of the target liquid medicine reaches a preset range, acquiring a first total atomization duration corresponding to the target liquid medicine;
acquiring the atomization efficiency of an atomization assembly of the atomizer for atomizing the target liquid medicine;
and calculating the inhalation atomization amount of the target user based on the first atomization total duration and the atomization efficiency.
5. The method of monitoring nebulized therapy of claim 1, wherein the step of obtaining a usage signal of the target patient further comprises:
acquiring a first flow data value of a first flow sensor corresponding to the atomizer;
determining a respiration state of the target user from the first flow data value;
and determining a use signal of the target user according to the breathing state.
6. The method of claim 4, wherein the step of determining the amount of nebulization of the target medical fluid after the current nebulization comprises:
When the total atomization amount of the target liquid medicine reaches a preset range, obtaining a second total atomization duration corresponding to the target liquid medicine;
determining a second flow data value for a second flow sensor within the second total nebulization duration;
the second flow data value is determined as the inhalation aerosol quantity of the target user.
7. A method of monitoring nebulization therapy according to claim 2 or 4, characterized in that the step of determining the usage signal of the target user from the respiratory status comprises:
generating an inhalation signal when the respiratory state is an inhalation state;
generating an expiration signal when the respiratory state is an expiration state;
wherein the inhalation signal and the exhalation signal are both the use signal;
the processing the target liquid medicine according to the use signal comprises the following steps:
atomizing the target liquid medicine when the using signal is an inhalation signal;
and when the use signal is an expiration signal, suspending atomization of the target liquid medicine.
8. A method of monitoring nebulization therapy according to claim 1, characterized in that the method further comprises:
establishing an atomized medicine library corresponding to the target user;
Deleting a first mark corresponding to the target liquid medicine from the atomized medicine library after the target liquid medicine is atomized;
if the target user is detected to atomize in the current period, matching a second identifier corresponding to the first liquid medicine atomized at present with the medicine identifier in the atomized medicine library;
if the atomized medicine library has medicine identifications matched with the second identifications, atomizing the first medicine liquid;
and if the atomized medicine library does not have the medicine identification matched with the second identification, sending out prompt information.
9. A method of monitoring nebulization therapy according to claim 8, characterized in that the method further comprises:
after the atomization of the target liquid medicine is completed, the identity of the target user is associated with the first identity;
if the target user is detected to atomize in the current period, judging whether a third identifier corresponding to the second liquid medicine which is atomized currently is matched with a liquid medicine identifier associated with the target user or not;
if the third identifier is matched with the liquid medicine identifier associated with the target user, a prompt message is sent;
and if the third identifier is not matched with the liquid medicine identifier associated with the target user, atomizing the second liquid medicine.
10. A monitoring system for nebulized therapy, comprising:
using a signal acquisition module: for acquiring a usage signal of the target patient;
the target liquid medicine treatment module: the device is used for processing the target liquid medicine according to the use signal, and the processing comprises atomizing the target liquid medicine or suspending atomizing the target liquid medicine;
the target liquid medicine output module: the device is used for outputting the atomized target liquid medicine after the target liquid medicine is atomized;
the atomization amount determining module is used for: when the atomization of the target liquid medicine is suspended, determining the atomization amount of the target liquid medicine after the current atomization;
and an atomization stopping module: and repeating the above operation until the total atomization amount of the target liquid medicine reaches a preset range, and stopping atomizing the target liquid medicine.
CN202311125909.5A 2023-09-01 2023-09-01 Monitoring method, system, equipment and storage medium for atomization treatment Pending CN117065157A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202311125909.5A CN117065157A (en) 2023-09-01 2023-09-01 Monitoring method, system, equipment and storage medium for atomization treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202311125909.5A CN117065157A (en) 2023-09-01 2023-09-01 Monitoring method, system, equipment and storage medium for atomization treatment

Publications (1)

Publication Number Publication Date
CN117065157A true CN117065157A (en) 2023-11-17

Family

ID=88704060

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202311125909.5A Pending CN117065157A (en) 2023-09-01 2023-09-01 Monitoring method, system, equipment and storage medium for atomization treatment

Country Status (1)

Country Link
CN (1) CN117065157A (en)

Similar Documents

Publication Publication Date Title
US11033700B2 (en) Leak determination in a breathing assistance system
US6845770B2 (en) Systems and methods for clearing aerosols from the effective anatomic dead space
JP5479465B2 (en) Interactive device and method for profiling inhalation efforts in real time
US7793660B2 (en) Method of treating obstructive sleep apnea
CN102186524B (en) Accessory connection and data synchronication in a ventilator
EP2139546B1 (en) Ventilator aerosol delivery
JP3085586B2 (en) Information processing inhaler that provides feedback to patients and healthcare professionals
US20050133024A1 (en) Devices for measuring inspiratory airflow
US20110000482A1 (en) Laboratory animal pulmonary dosing device
CA2362160A1 (en) Method and apparatus for controlling a medical ventilator
CN108366756B (en) Apparatus, system and method for determining breathing characteristics of a subject based on breathing gas
CN110114105A (en) Determine the pressure support device and method of the variation in patient circuit
CN117065157A (en) Monitoring method, system, equipment and storage medium for atomization treatment
US20230166058A1 (en) Method for estimating inhale dose of a person
CN116212177A (en) Atomization drug delivery system and control method thereof
CN117065155A (en) Liquid medicine atomizing device and method for portable atomizer and portable atomizer
JPS63242228A (en) Method and apparatus for evaluating and measuring appearance easiness of cough

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination